Feasibility of engaging gene therapeutic principles in intensifying classical chemotherapy.
Mickisch
G H
GH
Afdeling Urologie, Academisch Ziekenhuis Dijikzigt, Erasmus Universiteit, Rotterdam, Nederland.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D001693:Biological Transport, Active; D001853:Bone Marrow / Q000737:chemistry; D018076:DNA, Complementary / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics*; D005240:Feasibility Studies; D015870:Gene Expression; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011828:Radiation Chimera; D011993:Recombinant Fusion Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000737:chemistry
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D018076:DNA, Complementary; D011993:Recombinant Fusion Proteins